Skip to main content
TipRanks
Go Ultimate75% OFF

Steve Mitgang Insider Profile

4 Followers

Steve Mitgang, Director at Eterna Therapeutics, holds 1.81K shares in Eterna Therapeutics (Ticker: ERNA).

Steve Mitgang's Trading History

ERNA
Eterna Therapeutics
Oct 03, 2017DirectorUninformative Buy―$3.06K
ERNA
Insider Shares: 1.81K (0.07%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 03, 2017Uninformative Buy$0.00816$0.00―
Jul 05, 2017Uninformative Buy$0.00697$0.00―
Jun 19, 2015Informative Buy$2.50K10,000$0.25-62.30%
Jun 03, 2015Informative Buy$2.10K5,000$0.42-49.30%

You May Also Like

Steve Mitgang insider profile FAQ

What is the percentage of profitable transactions made by Steve Mitgang?
The percentage of profitable transactions made by Steve Mitgang is 0%.
What is the average return per transaction made by Steve Mitgang?
The average return per transaction made by Steve Mitgang is -55.80%.
What stocks does Steve Mitgang hold?
Steve Mitgang holds: ERNA stocks.
What was Steve Mitgang's most profitable transaction?
Steve Mitgang’s most profitable transaction was an Informative Buy of ERNA stock on June 3, 2015. The return on the trade was -49.30%.
What is Steve Mitgang's role in Eterna Therapeutics?
Steve Mitgang's role in Eterna Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.